Veradermics logo

Veradermics

Healthcare & Life Sciences

Recent Finacing

Series B

Recent Raise

$75M


Veradermics is a biopharmaceutical company developing an oral treatment for androgenetic alopecia.

Total Funding

$75M

Headquarters

New Haven, USA

Founded

N/A

Focus Areas

Biopharmaceutical
Dermatologic
Clinical Trial
Oral Treatment
Androgenetic Alopecia

Investors

Longitude Capital logo
Osage University Partners logo
Connecticut Innovations logo
Surveyor Capital logo
PhiFund logo
Suvretta Capital Management logo
JW Childs Associates logo